Company news
Assertio Holdings, Inc. news in 2019
Assertio Holdings, Inc.'s news releases, calls and decks from 2019, newest first.
Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million
December 11, 2019
Assertio Therapeutics Announces Third-Quarter 2019 Results
November 5, 2019
Assertio Therapeutics to Report Third-Quarter 2019 Financial Results After the Close of Markets on Wednesday, November 6, 2019
October 22, 2019
Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin
October 20, 2019
Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors
September 29, 2019